The Capybara home screen widget shows where you are on protein, water, fiber, and steps without opening the app which matters most on the days you would otherwise skip a glass of water or under-eat protein and not notice until the week feels rougher than expected
The only way to know if it's working for you is to track baseline metrics and compare
Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
A liverfirst approach includes: Confirming liver involvement with imaging and fibrosis assessments Evaluating comorbid metabolic conditions Tailoring lifestyle guidance to support hepatic outcomes Initiating GLP1s where appropriate for both metabolic and liver health Monitoring ALT/AST and noninvasive fibrosis scores alongside traditional outcomes Even in patients with normal A1C or lean body type, these therapies can play a role
it's a sign that your physiology has adjusted to the treatment